References
Reynolds JEF. ed. Martindale — The Extra Pharmacopoeia, 1993. London; 1993: 1–36.
Lanza LL, Walker AM, Bortnilhak EA, Gause DO, Dreyer NA. Incidence of symptomatic liver function abnormalities. Pharmacoepidemiol Drug Safety 1995; 4: 231–7.
Edwards RI. Fenbufen: Adverse reactions affecting the skin. N Z Med J 1988; 101: 550–2.
Szer IS, Goldenstein-Schinberg C, Kurtin PS. Paucity of renal complications associated with non steroidal anti-inflamatory drugs in children with chronic arthritis. J Pediatr 1991; 119; 815–7.
Feehally J, Wheeler DC, Mackay EH, Oldhan R, Walls J. Recurrent acute renal failure with interstital nephritis due to d-penicillamine. Ren Fail 1987; 10: 55–7.
Gaist D, Andersen M, Schou JS. Spontaneous reports of drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Denmark 1968–1991. Pharmacoepidemiol Drug Safety 1996; 5: 79–86.
Burton GH. Rash and pulmonary eosinophilia associated with fenbufen Br Med J 1990; 300: 82–3.
Garcia Rodriguez L, Perez-Guttham S, Walker AM, Lueck L. The role of non steroidal anti-inflamatory drugs in acute liver injury. Br Med J 1992; 305: 865–8.
Scully CJ, Clarke D, Barr RJ. Diclofenac induced hepatitis, 3 cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 1993; 38: 744–51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krivoy, N., Azzam, Z., Oren, I. et al. Interstitial nephritis, toxic epidermal necrolysis and liver dysfunction associated to fenbufen. Clin Rheumatol 16, 489–490 (1997). https://doi.org/10.1007/BF02238943
Issue Date:
DOI: https://doi.org/10.1007/BF02238943